Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 28,838 shares at $30.08 ($867K) on 2025-01-22, disclosed to the SEC on 2025-01-23.
Scheduled sale ($867k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 300 | $9K | 1.0% |
| 2 | $30.08 | 14,269 | $429K | 49.5% |
| 3 | $30.08 | 14,269 | $429K | 49.5% |
| Total | $30.08 avg | 28,838 | $867K | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |